RV
Ram Vishwakarma
About Ram Vishwakarma
Data last updated:
Ram Vishwakarma is an Additional Director at Biotech Consortium India Limited (since 2020), Director at Conjuvac (Opc) Private Limited (since 2022) and Director at Onco-Vac Biopharma Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Business Outsourcing, Research & Development and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹7.25 Cr; the largest is Biotech Consortium India Limited at ₹6.12 Cr (FY 2025). Earlier, Ram Vishwakarma was a Director at Galen Biopharma India Private Limited (2020–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biotech Consortium India Limited U73100DL1990PLC041486 | Additional Director | 28 Oct 2020 | 1990 | ₹6.12 Cr (FY 2025) | Active |
 Conjuvac (Opc) Private Limited U73100HR2022OPC107599 | Director | 09 Nov 2022 | 2022 | ₹1.13 Cr (FY 2025) | Active |
| Onco-Vac Biopharma Private Limited U73100DL2022PTC404697 | Director | 10 Feb 2023 | 2022 | ₹28,383 (FY 2025) | Active |
| Skei Oncotherapeutics Private Limited U73200TN2021PTC142058 | Additional Director | 07 Dec 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Galen Biopharma India Private Limited U73100MH2020PTC342833 | Director | 28 Jul 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ram Vishwakarma
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ram Vishwakarma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ram Vishwakarma
Ram Vishwakarma currently holds 4 directorships: Biotech Consortium India Limited (Additional Director, since 28 Oct 2020, revenue ₹6.12 Cr (FY 2025)); Conjuvac (Opc) Private Limited (Director, since 09 Nov 2022, revenue ₹1.13 Cr (FY 2025)); Onco-Vac Biopharma Private Limited (Director, since 10 Feb 2023, revenue ₹28,383 (FY 2025)); Skei Oncotherapeutics Private Limited (Additional Director, since 07 Dec 2021).
Ram Vishwakarma was first appointed on 28 Jul 2020 as Director at Galen Biopharma India Private Limited. The most recent appointment on record is 10 Feb 2023 at Onco-Vac Biopharma Private Limited.
The 3 current companies of Ram Vishwakarma that report revenue have a combined latest revenue of ₹7.25 Cr: Biotech Consortium India Limited ₹6.12 Cr (FY 2025); Conjuvac (Opc) Private Limited ₹1.13 Cr (FY 2025); Onco-Vac Biopharma Private Limited ₹28,383 (FY 2025).
Ram Vishwakarma held 1 earlier board appointment: Galen Biopharma India Private Limited (Director, 28 Jul 2020 to 13 Sep 2021).
The current boards of Ram Vishwakarma's companies include Anita Gupta (Biotech Consortium India Limited), Mukesh Gupta (Biotech Consortium India Limited), Phadnis Ramarao Suresh (Biotech Consortium India Limited), Purnima Sharma (Biotech Consortium India Limited), Ranjan Kumar Rath (Biotech Consortium India Limited), Sanghamitra Pati (Biotech Consortium India Limited), among others.